This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.

Select country
  • language Clinigen Australia
  • language Clinigen France
  • language Clinigen Germany
  • About Clinigen
    • About us
    • History
    • Board of Directors
    • Responsible business
    • Operational excellence
    • Our brands
  • Global offices
    • Australia & New Zealand
    • Mainland Europe
    • Japan
    • Asia
    • South Africa
    • United Kingdom
    • United States
  • Careers
    • Careers overview
    • Apply Online
    • Frequently Asked Questions
    • Privacy Notice - Applicants
  • Investors
    • At a Glance
    • Financial Highlights
    • Investment Case
      • Business Model
      • Our Track Record
      • Our Divisions
      • Strategy
    • Share Tools
    • Results, Reports and Presentations
    • Quantum Archive
    • Financial Calendar
    • Press Releases
      • Press Releases
      • Regulatory News
      • Email Alerts
    • Shareholder Services
      • AGM
      • Registrar Services
      • Major Shareholders
      • Advisor Contacts
      • Analyst Coverage
    • Corporate Governance
      • Corporate Governance Statement
      • Board of Directors
      • Tax Strategy
      • AIM Rule 26
    • Investor Contacts
  • Newsroom
    • Video Library
    • Press Releases
    • Stay In Touch
Clinigen-Logo.png
  • Mission
  • How we can help
    Pharmaceutical & Biotech Companies
    Healthcare Professionals
    Patient Groups
    Patients
  • Products & Services
    Products
    • Partnering
    • Divestment
    • Unlicensed Markets
    • Our Products
    Services
    • Managed Access Programs
    • Clinical Supplies Management
    • Real World Data
    • Medical Science Liaison (MSLs)

    Find a medicine

    Online services for healthcare professionals

    Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Special Obtains Aseptics UK
  • Insights
Find a medicine
Hard to find medicines (Clinigen Direct)
Managed Access Programs (Cliniport)
Clinigen Products
Special Obtains
Aseptics UK
Get in touch
Find a medicine
Hard to find medicines (Clinigen Direct)
Managed Access Programs (Cliniport)
Clinigen Products
Special Obtains
Aseptics UK
  • Mission
  • How we can help
    How we can help
    • Pharmaceutical & Biotech Companies
    • Healthcare Professionals
    • Patient Groups
    • Patients
  • Products & Services
    Products & Services
    • Products
      Products

      Products

      • Partnering
      • Divestment
      • Unlicensed Markets
      • Our Products
    • Services
      Services

      Services

      • Managed Access Programs
      • Clinical Supplies Management
      • Real World Data
      • Medical Science Liaison (MSLs)

    Find a medicine

    Online services for healthcare professionals

    Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Special Obtains Aseptics UK
  • Insights
  • About Clinigen
    About Clinigen

    About Clinigen

    • About us
    • History
    • Board of Directors
    • Responsible business
    • Operational excellence
    • Our brands
  • Global offices
    Global offices

    Global offices

    • Australia & New Zealand
    • Mainland Europe
    • Japan
    • Asia
    • South Africa
    • United Kingdom
    • United States
  • Careers
    Careers

    Careers

    • Careers overview
    • Apply Online
    • Frequently Asked Questions
    • Privacy Notice - Applicants
  • Investors
    Investors

    Investors

    • At a Glance
    • Financial Highlights
    • Investment Case
      Investment Case

      Investment Case

      • Business Model
      • Our Track Record
      • Our Divisions
      • Strategy
    • Share Tools
    • Results, Reports and Presentations
    • Quantum Archive
    • Financial Calendar
    • Press Releases
      Press Releases

      Press Releases

      • Press Releases
      • Regulatory News
      • Email Alerts
    • Shareholder Services
      Shareholder Services

      Shareholder Services

      • AGM
      • Registrar Services
      • Major Shareholders
      • Advisor Contacts
      • Analyst Coverage
    • Corporate Governance
      Corporate Governance

      Corporate Governance

      • Corporate Governance Statement
      • Board of Directors
      • Tax Strategy
      • AIM Rule 26
    • Investor Contacts
  • Newsroom
    Newsroom

    Newsroom

    • Video Library
    • Press Releases
    • Stay In Touch

Press Releases

  • About Clinigen
    • About us
    • History
    • Board of Directors
    • Responsible business
    • Operational excellence
    • Our brands
  • Careers
    • Careers overview
    • Apply Online
    • Frequently Asked Questions
    • Privacy Notice - Applicants
  • Newsroom
    • Video Library
    • Press Releases
    • Stay In Touch
  • 2021
  • 2020
  • 2019
  • 2018
  • Archive
More
Filter by
  • 08 Apr 2021

    Clinigen launches Managed Access Program with BeiGene for zanubrutinib

    Related materials
    PDF (205.69KB)
  • 06 Apr 2021

    Clinigen to begin supplying Erwinase® in the UK

    Related materials
    PDF (199.80KB)
  • 29 Mar 2021

    Clinigen Joins Decentralized Trials & Research Alliance (DTRA)

    Related materials
    PDF (188.56KB)
  • 24 Mar 2021

    Directorate Change

  • 15 Mar 2021

    Clinigen signs distribution agreement with Amgen in territories across Africa and Asia

    Related materials
    PDF (175.26KB)
  • 23 Feb 2021

    Half Year Results for the Six Months Ended 31 December 2020

    Related materials
    PDF (626.47KB) Presentation Webcast
Our global offices
  • Australia & New Zealand
  • Mainland Europe
  • Japan
  • Singapore
  • South Africa
  • United Kingdom
  • United States
Site
tools
  • Stay In Touch
Find a medicine

Online services for healthcare professionals

Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Clinigen Products Special Obtains Aseptics UK
  • Twitter
  • Vimeo
  • Linkedin
© Copyright 2021 Clinigen Group plc. By Emperor